Reports for BAUSCH HEALTH, CANADA INC.

Company Name

BAUSCH HEALTH, CANADA INC.

Totals

Shortage reports

71
Actual shortage: 4 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 8 (11%)
Resolved: 59 (83%)

Discontinuation Reports

0
To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

13 (18%)

Overdue reports

0 (0%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ETIBI 100MG TABLET Resolved 2019-06-07 2020-02-07 85828
ETIBI 400MG TABLET Resolved 2019-06-07 2020-02-28 85831
MESTINON 60MG TABLET Resolved 2019-06-21 2019-07-24 87189
MESTINON-SR 180MG TABLET (EXTENDED-RELEASE) Resolved 2018-04-06 2018-04-13 45130
NORITATE 1% CREAM Resolved 2018-06-29 2018-08-28 53251
NORITATE 1% CREAM Avoided shortage 2018-10-19 2018-11-09 64990
NORITATE 1% CREAM Resolved 2020-01-09 2020-02-14 102996
RETIN-A 0.05% CREAM Resolved 2017-08-17 2018-03-30 19739
RETIN-A 0.05% CREAM Avoided shortage 2019-01-23 2019-03-05 73391
RETIN-A 0.025% GEL Resolved 2018-04-06 2018-06-20 45139
RETIN-A 0.025% GEL Resolved 2019-03-22 2019-09-10 79311
ROFACT 300MG CAPSULE Actual shortage 2019-09-06 2020-02-28 93246
ROFACT 150MG CAPSULE Actual shortage 2019-09-06 2020-02-28 93236
ROFACT 150MG CAPSULE Resolved 2017-03-17 2017-06-16 3290
ROFACT 150MG CAPSULE Resolved 2017-05-26 2017-06-16 11360
ROFACT 300MG CAPSULE Resolved 2017-03-13 2017-04-12 1621
ROFACT 300MG CAPSULE Avoided shortage 2018-05-11 2018-07-09 49062
ROFACT 300MG CAPSULE Resolved 2018-10-29 2019-08-01 65751
SUBLINOX 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-02 2017-11-13 24049
SUBLINOX 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-03-02 2018-06-20 41546

Showing 41 to 60 of 71

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports